Croda International (OTCMKTS:COIHY) Sets New 12-Month High – Time to Buy?

Croda International PLC Unsponsored ADR (OTCMKTS:COIHY) hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as $22.29 and last traded at $21.96, with a volume of 7467 shares traded. The stock had previously closed at $20.3175.

Trending Headlines about Croda International

Here are the key news stories impacting Croda International this week:

• Positive Sentiment: Fourth-quarter and second-half results beat consensus: adjusted H2 EBIT came in ahead of forecasts and Q4 constant‑currency sales grew ~5%, above market expectations — a key catalyst for the stock. Croda impresses as turnaround shows further progress
• Positive Sentiment: Full‑year 2025 results at the top end of guidance: sales rose to ~£1.7bn (6.6% cc) and adjusted operating profit increased ~7.9% to £295.3m; margin nudged up to 17.4% — management also set multi‑year targets to further improve margins. Croda reports top-end profits and sets out new growth targets
• Positive Sentiment: Management signals early turnaround progress and expects margin gains as sales climb, providing constructive forward guidance on margin improvement initiatives. Croda International Plc (COIHY) Q4 2025 Earnings Call Transcript
• Neutral Sentiment: Mainstream coverage highlights the share rise and links it to stronger sales in Consumer Care and Life Sciences — useful confirmation for investors but reiterates the same company-reported figures. Croda International Shares Rise on Higher Sales in Consumer Care, Life Sciences
• Neutral Sentiment: Local and regional press summaries detail the full-year results and transformation work — helpful background but unlikely to move the stock by themselves. Croda International details full year results for 2025
• Negative Sentiment: Management flagged slower sales growth in the second half and noted “uncertain” market conditions; these macro/sector headwinds could limit near‑term upside if demand softens. Sales, profits spark at Croda despite ‘uncertain’ market conditions
• Negative Sentiment: Slower H2 growth tempers the story — investors should watch whether margin improvement targets are delivered over the next 12–36 months; execution risk remains. Croda reports top-end profits and sets out new growth targets

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group lowered Croda International from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, November 11th. One research analyst has rated the stock with a Strong Buy rating, one has given a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold”.

Croda International Stock Up 8.1%

The company’s 50-day moving average price is $19.22 and its two-hundred day moving average price is $18.41. The company has a debt-to-equity ratio of 0.23, a current ratio of 2.07 and a quick ratio of 1.19.

About Croda International

Croda International plc is a UK-based specialty chemicals company headquartered in East Yorkshire, England. Established in 1925, Croda has built a global reputation for developing and manufacturing high-performance ingredients derived primarily from natural oils and renewable resources. The company’s research-driven approach has enabled it to innovate across a wide range of sectors, delivering solutions that combine efficacy, sustainability and compliance with stringent regulatory standards.

Croda’s operations are organized around three core segments: Personal Care, Life Sciences and Performance Technologies.